Aerovate Therapeutics Inc. is a clinical-stage biopharmaceutical company developing drugs to treat rare cardiopulmonary diseases. Pulmonary Arterial Hypertension is a rare progressive and often fatal cardiopulmonary disease affecting both the heart and lungs. Aerovate's lead program, AV-101, is an inhalable dry to address the underlying hyperproliferation of cells within the narrowed arteries of the lungs. Aerovate Therapeutics was incorporated in 2018 and is headquartered in Waltham, MA.
What is Aerovate Therapeutics's quote symbol?
What is the 52 week high and low for Aerovate Therapeutics (NASDAQ: AVTE)?
How much is Aerovate Therapeutics stock worth today?
How much is Aerovate Therapeutics's stock price per share?
What is Aerovate Therapeutics's Market Cap?